Skip to main content
SCANCELL HOLDINGS PLC logo

SCANCELL HOLDINGS PLC — Investor Relations & Filings

Ticker · SCLP ISIN · GB00B63D3314 LEI · 2138008RXEG856SNP666 IL Professional, scientific and technical activities
Open in API
Filings indexed 436 across all filing types
Latest filing 2016-09-16 Annual Report
Country GB United Kingdom
Listing IL SCLP

About SCANCELL HOLDINGS PLC

https://www.scancell.co.uk/

Scancell Holdings PLC is a clinical-stage company developing novel active immunotherapies for the treatment of cancer. Its approach focuses on enhancing long-lasting, tumor-specific immunity to address significant unmet needs in oncology, particularly for hard-to-treat cancers. The company leverages its proprietary technology platforms, Immunobody®, Moditope®, and AvidiMab™, to create targeted, off-the-shelf therapies. The Immunobody® platform generates DNA-based immunotherapies, with its lead candidate, iSCIB1+, targeting advanced melanoma. The Moditope® platform develops peptide-based therapies, with a lead product showing encouraging Phase 2 data in a broad range of solid tumors. Scancell aims to deliver treatments that are safe, effective, easily administered, and accessible to patients.

Recent filings

Filing Released Lang Actions
Final Results
Annual Report Classification · 95% confidence The document is titled 'Final Results for the year ended 30 April 2016' and contains comprehensive financial data, including a Profit and Loss Account, Balance Sheet, and Chairman's Statement. It is a full annual financial report for the company Scancell Holdings Plc. While it is distributed via an RNS (Regulatory News Service) header, the content itself constitutes the full annual financial results, making it an Annual Report (10-K equivalent for this jurisdiction). FY 2016
2016-09-16 English
Appointment of Non-Executive Director
Board/Management Information Classification · 99% confidence The document begins with an 'RNS Number' and is dated August 22, 2016. The core content announces the appointment of Dr. Alan J. Lewis as a Non-Executive Director, detailing his background, current directorships, and includes standard boilerplate language about inside information and contact details typical of regulatory news service announcements. This clearly falls under the category of announcing changes in senior management or board composition. Therefore, the appropriate classification is Board/Management Information (MANG).
2016-08-22 English
Eurogentec manufacturing agreement
Regulatory Filings Classification · 98% confidence The document begins with an 'RNS Number' and the date, indicating it is a regulatory announcement disseminated via the Regulatory News Service (RNS). The content details a business agreement between Scancell Holdings Plc and Eurogentec for the manufacture of vaccine material (SCIB1) for clinical trials. This is a specific operational update concerning manufacturing and clinical supply, not a full financial report (10-K, IR), a management change (MANG), or a dividend announcement (DIV). Since it is a specific operational announcement distributed through the RNS system and doesn't fit neatly into the other specific operational categories (like CAP, TAR, LTR), the most appropriate classification is the general regulatory announcement category, RNS, as it is explicitly branded as an RNS release at the end.
2016-07-21 English
Extension to Ichor Commercial Option
Regulatory Filings Classification · 98% confidence The document begins with an 'RNS Number' and a date, indicating it is a regulatory announcement disseminated via the Regulatory News Service (RNS). The content describes a specific corporate action: the extension of a commercial option agreement between Scancell Holdings Plc and Ichor Medical Systems regarding the TriGrid® electroporation delivery system and SCIB1 vaccine. This is a material corporate event announcement, not a full financial report (like 10-K or IR), a transcript (CT), or a presentation (IP). Since it is a specific corporate update disseminated through the official regulatory channel (RNS), and it doesn't fit perfectly into categories like M&A (TAR) or Capital Change (CAP), the most appropriate general classification for a specific, non-financial-statement regulatory update is RNS, which serves as the general regulatory announcement category.
2016-07-20 English
SCIB1 compelling survival data in melanoma
Earnings Release Classification · 99% confidence The document begins with an 'RNS Number' and the date, indicating it is a regulatory announcement from the London Stock Exchange's RNS service. The content provides an update on clinical trial data (SCIB1) and announces that company executives will be presenting this information at two upcoming events: the Oxford Technology VCT AGM and the Proactive Investors One2One Forum. Since the primary purpose is to disseminate new operational/clinical information via a regulatory channel (RNS) and announce participation in investor events, it fits best as a general Regulatory Filing (RNS) or potentially an Earnings Release (ER) if the data were strictly financial results. However, given the format (RNS Number, END marker) and the focus on clinical trial updates and presentation schedules rather than formal financial statements, RNS is the most appropriate general regulatory category. It is not a full Annual Report (10-K), Interim Report (IR), or a specific management discussion (MDA). It is an announcement, not the presentation itself (IP) or the transcript (CT). FY 2015
2016-07-06 English
Second Price Monitoring Extn
Regulatory Filings Classification · 99% confidence The document is very short (1186 characters) and contains an 'RNS Number' header, indicating it is a regulatory announcement from the London Stock Exchange. The content describes a 'Second Price Monitoring Extension' related to trading activity, which is a specific market operational notice rather than a comprehensive financial report (like 10-K or IR) or a standard corporate disclosure (like ER or DIV). Since it is a general regulatory announcement that doesn't fit the highly specific categories (like DIRS, DIV, ER, etc.), the most appropriate fallback category is Regulatory Filings (RNS).
2016-06-29 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.